NewAmsterdam Pharma Company N.V. – NASDAQ:NAMS

NewAmsterdam Pharma Company N.V. stock price today

$24.45
-1.41
-5.45%
Financial Health
0
1
2
3
4
5
6
7
8
9

NewAmsterdam Pharma Company N.V. stock price monthly change

+30.15%
month

NewAmsterdam Pharma Company N.V. stock price quarterly change

+30.15%
quarter

NewAmsterdam Pharma Company N.V. stock price yearly change

+130.89%
year

NewAmsterdam Pharma Company N.V. key metrics

Market Cap
2.68B
Enterprise value
1.07B
P/E
-12.88
EV/Sales
N/A
EV/EBITDA
-37.89
Price/Sales
N/A
Price/Book
5.36
PEG ratio
0.03
EPS
-1.88
Revenue
109.29M
EBITDA
-111.18M
Income
-155.02M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
-101.73%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

NewAmsterdam Pharma Company N.V. stock price history

NewAmsterdam Pharma Company N.V. stock forecast

NewAmsterdam Pharma Company N.V. financial statements

Average Price Target
Last Year

$39.33

Potential upside: 60.87%

Based on estimate of 3 analysts
  • Analysts Price target

  • Financials & Ratios estimates

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS): Profit margin
Dec 2022 97.5M 20.36M 20.88%
Mar 2023 8.62M -42.01M -486.94%
Jun 2023 1.76M -39.59M -2246.8%
Mar 2024 1.40M -93.76M -6692.86%
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS): Earnings per share (EPS)
2024-02-28 -0.55 -0.54
2024-05-08 -0.54 -0.62
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS): Debt to assets
Jun 2023 471098000 48.83M 10.37%
Sep 2023 0 0
Dec 2023 347097000 58.70M 16.91%
Mar 2024 452699721 71.04M 15.69%
NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS): Cash Flow
Dec 2022 26.84M 715K 375.17M
Mar 2023 -31.86M -7K 2.39M
Jun 2023 -36.45M 5.62M 6.32M
Mar 2024 -54.60M -385K 198.18M

NewAmsterdam Pharma Company N.V. alternative data

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS): Employee count
Aug 2023 17
Sep 2023 22
Oct 2023 22
Nov 2023 22
Dec 2023 22
Jan 2024 22
Feb 2024 22
Mar 2024 29
Apr 2024 29
May 2024 29
Jun 2024 40
Jul 2024 40

NewAmsterdam Pharma Company N.V. other data

28.54% -71.46%
of NAMS is owned by hedge funds
3.23M -30.28M
shares is hold by hedge funds

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS): Insider trades (number of shares)
Period Buy Sel
Feb 2024 5000 0
Mar 2024 8429 190476
Jun 2024 5000 0
Aug 2024 5000 0
Sep 2024 1104 0
Oct 2024 0 45000
Nov 2024 0 52701
Dec 2024 0 462288
Transaction Date Insider Security Shares Price per share Total value Source
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 130,561 $25.26 $3,298,493
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 18,583 $26.41 $490,684
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 4,894 $27.11 $132,671
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 259,739 $25.22 $6,550,098
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 48,511 $26.15 $1,268,611
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 33,273 $25.08 $834,454
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 8,530 $25.02 $213,438
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 9,832 $25.01 $245,859
Sale
FORGROWTH NAP B.V. 10 percent owner
Ordinary Shares 1,066 $25 $26,654
Sale
KOOIJ LOUISE FREDERIKA officer: Chief Accounting Officer
Ordinary Shares 45,000 $15.72 $707,400
Friday, 13 December 2024
globenewswire.com
Wednesday, 11 December 2024
globenewswire.com
seekingalpha.com
Tuesday, 10 December 2024
globenewswire.com
benzinga.com
globenewswire.com
Friday, 6 December 2024
globenewswire.com
Wednesday, 20 November 2024
investors.com
Monday, 18 November 2024
globenewswire.com
Friday, 1 November 2024
globenewswire.com
Monday, 28 October 2024
globenewswire.com
Friday, 4 October 2024
globenewswire.com
seekingalpha.com
Friday, 6 September 2024
globenewswire.com
Friday, 30 August 2024
globenewswire.com
Wednesday, 28 August 2024
benzinga.com
Friday, 2 August 2024
globenewswire.com
Monday, 29 July 2024
investors.com
Friday, 26 July 2024
globenewswire.com
Monday, 8 July 2024
globenewswire.com
Friday, 5 July 2024
seekingalpha.com
Wednesday, 3 July 2024
globenewswire.com
Friday, 7 June 2024
globenewswire.com
Thursday, 9 May 2024
globenewswire.com
Friday, 3 May 2024
globenewswire.com
Tuesday, 9 April 2024
globenewswire.com
businesswire.com
Monday, 1 April 2024
globenewswire.com
Monday, 25 March 2024
GlobeNewsWire
Wednesday, 13 March 2024
Zacks Investment Research
  • What's the price of NewAmsterdam Pharma Company N.V. stock today?

    One share of NewAmsterdam Pharma Company N.V. stock can currently be purchased for approximately $24.45.

  • When is NewAmsterdam Pharma Company N.V.'s next earnings date?

    Unfortunately, NewAmsterdam Pharma Company N.V.'s (NAMS) next earnings date is currently unknown.

  • Does NewAmsterdam Pharma Company N.V. pay dividends?

    No, NewAmsterdam Pharma Company N.V. does not pay dividends.

  • How much money does NewAmsterdam Pharma Company N.V. make?

    NewAmsterdam Pharma Company N.V. has a market capitalization of 2.68B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 86.91% to 12.76M US dollars. NewAmsterdam Pharma Company N.V. made a loss 176.94M US dollars in net income (profit) last year or -$0.62 on an earnings per share basis.

  • What is NewAmsterdam Pharma Company N.V.'s stock symbol?

    NewAmsterdam Pharma Company N.V. is traded on the NASDAQ under the ticker symbol "NAMS".

  • What is NewAmsterdam Pharma Company N.V.'s primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of NewAmsterdam Pharma Company N.V.?

    Shares of NewAmsterdam Pharma Company N.V. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does NewAmsterdam Pharma Company N.V. have?

    As Jul 2024, NewAmsterdam Pharma Company N.V. employs 40 workers, which is 38% more then previous quarter.

  • When NewAmsterdam Pharma Company N.V. went public?

    NewAmsterdam Pharma Company N.V. is publicly traded company for more then 4 years since IPO on 9 Feb 2021.

  • What is NewAmsterdam Pharma Company N.V.'s official website?

    The official website for NewAmsterdam Pharma Company N.V. is newamsterdampharma.com.

  • How can i contact NewAmsterdam Pharma Company N.V.?

    NewAmsterdam Pharma Company N.V. can be reached via phone at +31 35 206 2971.

  • What is NewAmsterdam Pharma Company N.V. stock forecast & price target?

    Based on 3 Wall Street analysts` predicted price targets for NewAmsterdam Pharma Company N.V. in the last 12 months, the avarage price target is $39.33. The average price target represents a 60.87% change from the last price of $24.45.

NewAmsterdam Pharma Company N.V. company profile:

NewAmsterdam Pharma Company N.V.

newamsterdampharma.com
Exchange:

NASDAQ

Full time employees:

62

Industry:

Biotechnology

Sector:

Healthcare

NewAmsterdam Pharma Company N.V., a clinical-stage biopharmaceutical company, focuses on improving patient care in populations with metabolic diseases. Its lead investigational candidate, obicetrapib, is a novel, selective inhibitor that targets the Cholesteryl Ester Transfer Protein (CETP), which has been clinically shown to reduce low-density lipoprotein cholesterol (LDL-C) while at the same time substantially increase high-density lipoprotein cholesterol (HDL-C). The company was founded in 2019 and is based in Naarden, the Netherlands.

Gooimeer 2-35
Naarden, 1411 DC

CIK: 0001936258
ISIN: NL00150012L7
: